Predictors of early and late mother-to-child transmission of HIV in a breastfeeding population: HIV network for prevention trials 012 experience, Kampala, Uganda

Journal of Acquired Immune Deficiency Syndromes

Volumn 52, Issue 1, 2009, Pages 32-39

  Mmiro, Francis A ^a   Aizire, Jim ^a   Mwatha, Anthony K ^b   Eshleman, Susan H ^c   Donnell, Deborah ^b   Fowler, Mary Glenn ^c   Nakabiito, Clemensia ^a   Musoke, Philippa M ^a   Jackson, J Brooks ^c   Guay, Laura A ^a,c  

^a MU UCSF Research Collaboration   (Uganda)

^b Fred Hutchinson Cancer Research Center   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Early late postnatal; HIV 1; MTCT

Indexed keywords

NEVIRAPINE; ZIDOVUDINE;

ARTICLE; BREAST FEEDING EDUCATION; DATA ANALYSIS; DRUG EFFICACY; GENE MUTATION; GENOTYPE; HAZARD RATIO; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFANT; MAJOR CLINICAL STUDY; MORBIDITY; MOTHER CHILD RELATION; POINT MUTATION; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; UGANDA; VIRUS TRANSMISSION;

ANTI-HIV AGENTS; BREAST FEEDING; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MULTIVARIATE ANALYSIS; NEVIRAPINE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROPORTIONAL HAZARDS MODELS; UGANDA; VIRAL LOAD; ZIDOVUDINE;

EID: 69549110329     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181afd352     Document Type: Article

References (30)

1. 2008 Report on the Global AIDS Epidemic. UNAIDS 2008. Available at: http://www.unaids.org/en/KnowledgeCentre/HIVData/GlobalReport/2008/ 2008-Global-report.asp. Accessed December 30, 2009.
2. WHO Expert Consultation on new and emerging evidence on the use of antiretroviral drugs for the prevention of mother-to-child transmission of HIV. Geneva, November 17-19, 2008. Available at: http://www.who.int/hiv/topics/mtct/ en/. Accessed January 2, 2009.
3. Kourtis AP, Bulterys M, Nesheim SR, et al. Understanding the timing of HIV transmission from mother to infant. JAMA. 2001;285:709-712. (Pubitemid 32167219)
4. Newell ML. Mechanisms and timing of mother-to-child transmission of HIV-1. AIDS. 1998;12:831-837. (Pubitemid 28241395)
5. Dabis F, Ekpini ER. HIV-1/AIDS and maternal and child health in Africa. Lancet. 2002;359:2097-2104. (Pubitemid 34680979)
6. De Cock K, Fowler MG, Mercier E, et al. Prevention of mother-to-child HIV transmission in resource- poor countries: translating research into policy and practice. JAMA. 2000;283:1175-1182. (Pubitemid 30126606)
7. Nduati R, John G, Mbori-Ngacha D, et al. Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial. JAMA. 2000;283:1167-1174. (Pubitemid 30126605)
8. Moodley D, Moodley J, Coovadia H, et al. A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to child transmission of human immunodeficiency virus type 1. J Infect Dis. 2003;187:725-735. (Pubitemid 36286932)
9. The BHITS Group. Late postnatal transmission of HIV-1 in breast-fed children: an individual patient data meta-analysis. J Infect Dis. 2004;189:2154-2166.
10. Miotti PG, Taha TE, Kumwenda NI, et al. HIV transmission through breastfeeding: a study in Malawi. JAMA. 1999;282:744-749. (Pubitemid 29404380)
11. Leroy V, Newell ML, Dabis F, et al. International multicentre pooled analysis of late post natal mother-to-child transmission of HIV-1 infection. Lancet. 1998;352:597-600. (Pubitemid 28380139)
12. Coutsoudis A, Rollins N. Breast-feeding and HIV transmission: the jury is still out. J Pediatr Gastroenterol Nutr. 2003;36:434-442. (Pubitemid 39280879)
13. John GC, Nduati R, Mbori-Ngacha DA, et al. Correlates of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission: Association with maternal plasma HIV-1 RNA load, genital HIV-1 DNA shedding, and breast infections. J Infect Dis. 2001;183:206-212. (Pubitemid 32066020)
14. Semba RD, Kumwenda N, Hoover DR, et al. Human immunodeficiency virus load in breast milk, mastitis and mother-to-child transmission of human immunodeficiency virus type 1. J Infect Dis. 1999;180:93-98. (Pubitemid 29293922)
15. de Martino M, Tovo PA, Tozzi AE, et al. HIV-1 transmission through breast milk: appraisal of risk according to duration of feeding. AIDS. 1992;6:991-997.
16. Eshleman SH, Hoover DR, Chen S, et al. Resistance after single dose nevirapine prophylaxis emerges in a high proportion of Malawian newborns. AIDS. 2005;19:2167-2169. (Pubitemid 41669007)
17. Guay LA, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomized trial. Lancet. 1999;354:795-802.
18. Jackson JB, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18 month follow up of the HIVNET 012 randomized trial. Lancet. 2003;362:859-868.
19. Jamieson DJ, Sibailly TS, Sadek R, et al. HIV-1 viral load and other risk factors for mother-to-child transmission of HIV-1 in a breast-feeding population in Cote d'Ivoire. J Acquir Immune Defic Syndr. 2003;34:430-436. (Pubitemid 37444472)
20. The Petra Study Team. The Petra trial: the efficacy of three short course regimens of zidovudine and lamivudine (3TC) in preventing early and late transmission of HIV-1 from mother-to-child in an African setting: a randomized, double-blind placebo-controlled trial; conducted in South Africa, Tanzania, and Uganda. Lancet. 2002;359:1178-1186.
21. Wiktor SZ, Ekpini ER, Karon JM, et al. Short course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Cote d'Ivoire: a randomized trial. Lancet. 1999;353:781-785.
22. Triques K, Coste J, Perret JL, et al. Efficiencies of four versions of the AMPLICOR HIV-1 MONITOR test for quantification of different subtypes of human immunodeficiency virus type 1. J Clin Microbiol. 1999;37:110-116. (Pubitemid 29004189)
23. Eshleman SH, Becker-Pergola G, Deseyve M, et al. Impact of HIV-1 subtype on women receiving single dose NVP prophylaxis to prevent HIV-1 vertical transmission (HIVNET 012). J Infect Dis. 2001;184:914-917. (Pubitemid 32980636)
24. Eshleman SH, Guay LA, Mwatha A, et al. Characterization of nevirapine (NVP) resistance mutations in women with subtype A vs. D HIV-1 6-8 weeks after single dose NVP (HIVNET 012). J Acquir Immune Defic Syndr. 2004;35:126-130. (Pubitemid 38133734)
25. Flys TS, Chen S, Jones DC, et al. Quantitative analysis of HIV-1 variants with the K103N resistance mutation after single dose nevirapine in women with HIV-1 subtypes A, C and D. J Acquir Immune Defic Syndr. 2006;42:610-613. (Pubitemid 44162432)
26. Chung MH, Kiarie JN, Richardson BA, et al. Breast milk HIV-1 suppression and decreased transmission: a randomized trial comparing HIVNET 012 nevirapine versus short-course zidovudine. AIDS. 2005;19:1415-1422.
27. Thior I, Lockman S, Smeaton LM, et al. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs. formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana. A randomized trial: The Mashi Study. JAMA. 2006;296:794-805.
28. Eshleman SH, Mracna M, Guay LA, et al. Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012). AIDS. 2001;15:1951-1957. (Pubitemid 32980636)
29. Flys TS, Donnell D, Mwatha A, et al. Persistence of K103N-containing HIV-1 variants after single-dose nevirapine for prevention of HIV-1 mother-to-child transmission. J Infect Dis. 2007;195:711-715. (Pubitemid 46273046)
30. Embree JE, Njenga S, Datta P, et al. Risk factors for postnatal mother-to-child transmission of HIV-1. AIDS. 2000;14:2535-2541. (Pubitemid 30840045)